The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
HALO NEWSLETTER
Keep reading HALO with a Free Subscription
unlock this story instantly and join members and pros reading HALO daily
-It's
Free